FR2382450A1 - Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols - Google Patents

Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols

Info

Publication number
FR2382450A1
FR2382450A1 FR7806161A FR7806161A FR2382450A1 FR 2382450 A1 FR2382450 A1 FR 2382450A1 FR 7806161 A FR7806161 A FR 7806161A FR 7806161 A FR7806161 A FR 7806161A FR 2382450 A1 FR2382450 A1 FR 2382450A1
Authority
FR
France
Prior art keywords
agents
pyridine
thiols
application
training
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7806161A
Other languages
English (en)
French (fr)
Other versions
FR2382450B1 (US20070117153A1-20070524-C00031.png
Inventor
Jan Per Erik Carlsson
Rolf Erik Axel Verner Axen
Hakan Nils Yngve Drevin
Goran Einar Samuel Lindgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Pharmacia Fine Chemicals AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Fine Chemicals AB filed Critical Pharmacia Fine Chemicals AB
Publication of FR2382450A1 publication Critical patent/FR2382450A1/fr
Application granted granted Critical
Publication of FR2382450B1 publication Critical patent/FR2382450B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7806161A 1977-03-04 1978-03-03 Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols Granted FR2382450A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7702462A SE430062B (sv) 1977-03-04 1977-03-04 Kopplings- eller tioleringsreagens

Publications (2)

Publication Number Publication Date
FR2382450A1 true FR2382450A1 (fr) 1978-09-29
FR2382450B1 FR2382450B1 (US20070117153A1-20070524-C00031.png) 1982-11-05

Family

ID=20330623

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7806161A Granted FR2382450A1 (fr) 1977-03-04 1978-03-03 Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols

Country Status (6)

Country Link
US (1) US4149003A (US20070117153A1-20070524-C00031.png)
JP (2) JPS53130674A (US20070117153A1-20070524-C00031.png)
DE (1) DE2808523A1 (US20070117153A1-20070524-C00031.png)
FR (1) FR2382450A1 (US20070117153A1-20070524-C00031.png)
GB (1) GB1597756A (US20070117153A1-20070524-C00031.png)
SE (1) SE430062B (US20070117153A1-20070524-C00031.png)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
FR2446287A1 (fr) * 1979-01-12 1980-08-08 Toyo Jozo Kk Nouveau compose disulfure polyfonctionnel
EP0064040A1 (en) * 1981-04-06 1982-11-03 Pharmacia Aktiebolag Therapeutically active disulphide compounds and their use
EP0074271A1 (en) * 1981-09-08 1983-03-16 Ortho Diagnostic Systems Inc. Double antibody conjugate
WO1983002946A1 (en) * 1982-02-26 1983-09-01 Relyveld, Edgar, Hans Antitumoral agents, such as daunorubicin, having an improved activity, obtention thereof and method for enhancing the activity of antitumoral agents
EP0234600A1 (en) * 1983-02-25 1987-09-02 The Upjohn Company Ligand/receptor pair-binding compounds
EP0240200A2 (en) * 1986-03-17 1987-10-07 Cetus Corporation Cross-linking agents, their use and preparation
EP0283563A2 (en) * 1983-12-24 1988-09-28 Beecham Group Plc Novel derivatives
EP0405578A2 (en) * 1989-06-29 1991-01-02 Nippon Shoji Kabushiki Kaisha Enzyme immunoassay for antigen and solid phase used therefor
EP0457250A2 (en) * 1990-05-14 1991-11-21 Bristol-Myers Squibb Company Novel bifunctional linking compounds, conjugates and methods for their production

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8003732L (sv) * 1980-05-19 1981-11-20 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
US4563304A (en) * 1981-02-27 1986-01-07 Pharmacia Fine Chemicals Ab Pyridine compounds modifying proteins, polypeptides or polysaccharides
SE8102194L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
SE8302758L (sv) * 1983-05-17 1984-11-18 Pharmacia Ab Sett for uppspjelkning av disulfidbindningar och derigenom erhallen forening
DE3587845T2 (de) * 1984-12-03 1994-10-20 Hoechst Celanese Corp Verfahren zur Bestimmung eines Liganden.
US4880935A (en) * 1986-07-11 1989-11-14 Icrf (Patents) Limited Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
JPS6391563A (ja) * 1986-10-07 1988-04-22 Nitsusui Seiyaku Kk 細菌由来蛋白特異抗原の検査法
US4794082A (en) * 1987-02-17 1988-12-27 Hoechst Celanese Corporation Biotinylating agents
US4798795A (en) * 1987-02-17 1989-01-17 Hoechst Celanese Corporation Biotinylating agents
US4709037A (en) * 1987-02-17 1987-11-24 Hoechst Celanese Corporation Biotinylating agents
JPS63189278U (US20070117153A1-20070524-C00031.png) * 1987-05-28 1988-12-05
DE3809986A1 (de) * 1988-03-24 1989-10-05 Boehringer Mannheim Gmbh Verbindungen zur einfuehrung einer sh-gruppe in tyrosin
JPH0253770U (US20070117153A1-20070524-C00031.png) * 1988-10-12 1990-04-18
WO1992001938A1 (en) * 1990-07-20 1992-02-06 City Of Hope Derivatization of c-terminal proline
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
US20030176512A1 (en) * 1998-08-11 2003-09-18 Kirkpatrick D. Lynn Asymmetric disulfides and methods of using same
US6552060B1 (en) 1997-08-11 2003-04-22 Prolx Pharmaceuticals, Inc. Asymmetric disulfides and methods of using same
AR030612A1 (es) * 2000-09-12 2003-08-27 Smithkline Beecham Corp Procedimiento e intermedios
JP2006500364A (ja) * 2002-08-16 2006-01-05 イムノージェン インコーポレーテッド 高い反応性と溶解度を有する架橋剤および小分子薬物の標的化送達用コンジュゲートの調製におけるそれらの使用
AU2003284304B8 (en) 2002-10-21 2009-08-06 Nagler, Richard Surface coating comprising bioactive compound
US7858108B2 (en) 2003-10-21 2010-12-28 Richard Nagler Elutable surface coating
BRPI0511350A (pt) * 2004-07-02 2007-12-04 Genentech Inc composto, métodos de indução da apoptose em uma célula, de sensibilização de uma célula à um sinal apoptótico, de inibição da ligação de uma proteìna iap e de tratamento de uma doença e cáncer e usos de um composto
NZ555601A (en) 2004-12-09 2009-07-31 Centocor Inc Anti-integrin immunoconjugates, methods and uses
NZ589670A (en) 2004-12-20 2013-01-25 Genentech Inc Pyrrolidine inhibitors of iap
US20110166319A1 (en) * 2005-02-11 2011-07-07 Immunogen, Inc. Process for preparing purified drug conjugates
ES2503719T3 (es) * 2005-02-11 2014-10-07 Immunogen, Inc. Procedimiento para preparar conjugados de anticuerpos y de maitansinoides
EA013327B1 (ru) 2005-08-24 2010-04-30 Иммуноджен, Инк. Способ приготовления очищенных конъюгатов лекарственных средств
AU2006340014B2 (en) * 2005-12-19 2012-12-20 Genentech, Inc. Inhibitors of IAP
US20070260041A1 (en) * 2006-05-03 2007-11-08 David Crich Allylic disulfide rearrangement and desulfurization method for the preparation of allylic sulfides
KR20090094461A (ko) * 2006-12-19 2009-09-07 제넨테크, 인크. Ｉａｐ의 이미다조피리딘 억제제
CA2683392A1 (en) * 2007-04-30 2008-11-06 Genentech, Inc. Inhibitors of iap
AU2009203971A1 (en) * 2008-01-11 2009-07-16 Genentech, Inc. Inhibitors of IAP
CA2730448A1 (en) 2008-08-02 2010-02-11 Genentech, Inc. Inhibitors of iap
EP3480202A1 (en) 2009-06-03 2019-05-08 ImmunoGen, Inc. Conjugation methods
RS58367B1 (sr) 2011-03-29 2019-03-29 Immunogen Inc Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
MX359599B (es) 2012-10-04 2018-09-12 Immunogen Inc Uso de una membrana de pvdf para purificar conjugados de agentes de unión celular y agentes citotóxicos.
US9518017B2 (en) 2013-06-28 2016-12-13 Immunogen, Inc. Purification of intermediates used in the preparation of heterobifunctional linkers
KR102325753B1 (ko) 2019-12-20 2021-11-11 주식회사 포스코 흑색 도금 강판 및 그 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872450A (en) * 1955-12-06 1959-02-03 Bayer Ag Thio- and dithio-carboxylic acid esters and a process for their manufacture
US3950348A (en) * 1971-12-30 1976-04-13 Merck & Co., Inc. Process for preparing e-pyridyl-4-methyloxycarbonyllysine

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
FR2446287A1 (fr) * 1979-01-12 1980-08-08 Toyo Jozo Kk Nouveau compose disulfure polyfonctionnel
EP0064040A1 (en) * 1981-04-06 1982-11-03 Pharmacia Aktiebolag Therapeutically active disulphide compounds and their use
EP0074271A1 (en) * 1981-09-08 1983-03-16 Ortho Diagnostic Systems Inc. Double antibody conjugate
WO1983002946A1 (en) * 1982-02-26 1983-09-01 Relyveld, Edgar, Hans Antitumoral agents, such as daunorubicin, having an improved activity, obtention thereof and method for enhancing the activity of antitumoral agents
FR2522269A1 (fr) * 1982-02-26 1983-09-02 Pasteur Institut Agents antitumoraux, tels que la daunorubicine, a efficacite amelioree, leur obtention et procede pour augmenter l'efficacite des agents antitumoraux
EP0088022A1 (fr) * 1982-02-26 1983-09-07 Institut Pasteur Agents antitumoraux à efficacité améliorée, leur obtention et procédé pour augmenter l'efficacité des agents antitumoraux
US4625019A (en) * 1982-02-26 1986-11-25 Institut Pasteur Polymeric product of daunorubicin and glutaraldehyde
EP0234600A1 (en) * 1983-02-25 1987-09-02 The Upjohn Company Ligand/receptor pair-binding compounds
EP0283563A2 (en) * 1983-12-24 1988-09-28 Beecham Group Plc Novel derivatives
EP0283563A3 (en) * 1983-12-24 1988-11-23 Beecham Group Plc Novel derivatives
EP0240200A2 (en) * 1986-03-17 1987-10-07 Cetus Corporation Cross-linking agents, their use and preparation
EP0240200A3 (en) * 1986-03-17 1990-03-28 Cetus Corporation Cross-linking agents, their use and preparation
EP0405578A2 (en) * 1989-06-29 1991-01-02 Nippon Shoji Kabushiki Kaisha Enzyme immunoassay for antigen and solid phase used therefor
EP0405578A3 (en) * 1989-06-29 1991-05-29 Nippon Shoji Kabushiki Kaisha Enzyme immunoassay for antigen and solid phase used therefor
EP0620438A1 (en) * 1989-06-29 1994-10-19 Nippon Shoji Kabushiki Kaisha Enzyme immunoassay for antigen and solid phase used therefor
EP0457250A2 (en) * 1990-05-14 1991-11-21 Bristol-Myers Squibb Company Novel bifunctional linking compounds, conjugates and methods for their production
EP0457250A3 (en) * 1990-05-14 1992-07-01 Bristol-Myers Squibb Company Novel bifunctional linking compounds, conjugates and methods for their production

Also Published As

Publication number Publication date
GB1597756A (en) 1981-09-09
SE7702462L (sv) 1978-09-05
US4149003A (en) 1979-04-10
JPS624368B2 (US20070117153A1-20070524-C00031.png) 1987-01-30
JPS6121227B2 (US20070117153A1-20070524-C00031.png) 1986-05-26
JPS61191675A (ja) 1986-08-26
DE2808523A1 (de) 1978-09-07
DE2808523C2 (US20070117153A1-20070524-C00031.png) 1987-11-19
FR2382450B1 (US20070117153A1-20070524-C00031.png) 1982-11-05
JPS53130674A (en) 1978-11-14
SE430062B (sv) 1983-10-17

Similar Documents

Publication Publication Date Title
FR2382450A1 (fr) Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols
FR2387954A1 (fr) Derives de mercaptoalkylsulfonylproline et composes apparentes, et leur utilisation comme medicaments
FR2391183A1 (fr) Hydroxyalkylphenones et leur application comme photosensibilisateurs
FR2377377A1 (fr) Amides derives du trimethoxy-3,4,5 benzene et leur application comme medicaments
FR2390420A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2377418A1 (fr) Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
FR2445323A2 (fr) Amides d'alkylenediamines et leur application en therapeutique
FR2422643A1 (fr) Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments
FR2391209A1 (fr) Aminoalkyl thiophenes, utiles comme medicaments, leur preparation et compositions en contenant
FR2432511A1 (fr) Derives triazoliques, leur preparation et leur application en tant que medicaments
FR2401135A1 (fr) Nouveaux derives d'aminoalkyl-benzenes et procedes pour leur preparation
FR2387988A1 (fr) Esters de cefuroxime, leur preparation et leur application therapeutique
FR2436149A1 (fr) Nouveaux aminoglucosides, leur preparation et leur application comme medicaments
FR2390446A1 (fr) Nouvelles triazines 1,3,5-s-hexahydrotrisubstituees, leur preparation et leur application a la lutte contre le developpement microbien
FR2423485A1 (fr) Nouvelles 1,3-diaryl-2-imino-imidazolidines et 1,3-diaryl-2-imino-hexahydro-pyrimidines substituees, procedes de preparation de ces composes et medicaments les contenant
FR2427335A1 (fr) Derives du 5-nitro-imidazole, leur preparation et leurs utilisations comme medicaments antiprotozoaires
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2393793A1 (fr) Derives de dichloro-3,3 azetidinones-2 a substituants basiques, leur procede de preparation et leur utilisation comme medicaments anti-inflammatoires
FR2382449A1 (fr) Halogenures de dithienylalkyle, leur preparation et leur application comme produits intermediaires dans la preparation de dithienylalkylamines
FR2401935A1 (fr) Nouveaux 25-alkylcholesterols utiles notamment comme hypocholesterolemiants et leur procede de preparation
FR2399465A1 (fr) Nouveaux complexes chromiferes 1 : 2, leur preparation et leur application comme colorants
FR2433536A1 (fr) Nouveaux derives de l'androst 4-ene, leur procede de preparation et leur application comme medicament
FR2432513A1 (fr) Nouveaux derives de la thiazoline et leur application comme medicaments
FR2433017A1 (fr) Derives de la phtalazone-1 et medicaments qui en contiennent
FR2392011A1 (fr) Nouveaux derives de la 5-phenyl-1h-3-benzazepine, leur preparation et leur utilisation comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse